secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001493152-26-007616
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience shareholders approve increase in authorized shares to 250M
--------------------------------------------------------------------------

- Approved amendment increasing authorized common shares from 200M to 250M, with 63.87% of outstanding shares voting for.
- Elected 7 directors, each receiving over 96% of votes cast.
- Ratified Weinberg & Company as auditor for FY 2026 (99.81% approval).
- Advisory vote on executive compensation passed with 96.68% support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226007616/0001493152-26-007616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226007616/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer